For decades, scientists believed that certain genetic mutations automatically caused disease. New research is dismantling that assumption, revealing that many so-called “monogenic diseases” are far more genetically complex than previously understood.
The established model held that specific single-gene mutations caused disease in nearly 100% of people carrying them. These conditions span a wide range, from thyroid cancer and ovarian insufficiency to certain forms of diabetes and retinal disorders. But population-based studies are now identifying large numbers of healthy individuals who carry those same mutations and show no signs of illness whatsoever.
Challenging the Core Assumption
Caroline Wright, a professor of genomic medicine at the University of Exeter in England, has been at the center of this research. Her work found gene variants that appear to cause disease consistently in patient samples, yet appear in only a minority of people in the general population without any apparent effect.
“It kind of challenges our standard dogma,” Wright said. “In much of single-gene genetics we’ve often assumed that a particular genetic cause is necessary and sufficient, and everything else is irrelevant. And what we’re seeing is that that’s not necessarily true.”
The implication is significant. If a mutation does not reliably produce a disease, then the mutation alone cannot be the complete explanation.
What Penetrance Actually Means
The concept at the center of this shift is “penetrance,” the likelihood that a person carrying a particular genetic variant will actually express the associated disease or trait. A mutation with 100% penetrance, like the one responsible for Tay-Sachs disease, causes illness in every individual who inherits two copies. But many mutations long classified this way are proving to have far lower penetrance than believed.
The original framework traces back to Gregor Mendel and his 19th-century pea plant experiments, which established dominant and recessive inheritance. Those rules still hold at the basic level. The problem is that genetics rarely stays at the basic level. Genes interact with each other and with environmental factors, and those interactions shape what traits or conditions a person actually develops.
Retinal diseases have emerged as a particularly clear example. Conditions once attributed cleanly to single-gene mutations are turning out to involve multiple genetic contributors, environmental variables, and factors that researchers are still working to identify.
Real Consequences for Patients
The findings carry direct practical weight for genetic counseling. When a patient with a family history of a genetic condition receives a positive result for a known mutation, the current model often treats that result as near-certain evidence of future disease. If penetrance is actually much lower than assumed, those counseling conversations need to change.
Treatment development is also affected. Therapies designed around correcting or blocking a single causative mutation may be addressing only part of the picture, particularly in cases where the disease requires additional genetic or environmental conditions to manifest.
The research does not overturn Mendelian genetics. It refines how scientists apply those principles to complex biological systems. The distinction between monogenic and polygenic disease, it turns out, may be less clear than textbooks have long suggested.
Photo by National Cancer Institute on Unsplash
This article is a curated summary based on third-party sources. Source: Read the original article
